Insider · CIK 0001228865

MOULDER LEON O JR

Reports to the SEC for 8 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001228865

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	ZLABZai Lab LtdA Award	Director	AAward	+22.4K sh	—	—	94,973
2026-06-15	ZBIOZenas BioPharma, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+500K sh	—	—	500,000
2026-05-18	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+60K sh	$16.88	+$1.01M	96,928
2026-04-29	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+35K sh	$17.62	+$617K	1,786,039
2026-04-28	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+25K sh	$18.02	+$451K	1,751,039
2026-03-31	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+34K sh	$19.31	+$657K	1,726,039
2026-03-30	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+20K sh	$18.23	+$365K	1,692,039
2026-02-02	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+57K sh	$17.96	+$1.02M	423,155
2026-01-09	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+20K sh	$16.55	+$331K	366,155
2026-01-08	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+30K sh	$16.30	+$489K	346,155
2026-01-07	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+50K sh	$16.38	+$819K	316,155
2025-10-07	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+36.9K sh	$20.85	+$770K	36,928
2025-06-18	ZLABZai Lab LtdA Award	Director	AAward	+10.8K sh	—	—	72,602
2025-06-10	ZBIOZenas BioPharma, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+400K sh	—	—	400,000
2025-02-18	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+25K sh	$6.67	+$167K	266,155
2024-12-04	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+45K sh	$9.98	+$449K	241,155
2024-12-03	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+25K sh	$10.76	+$269K	196,155
2024-11-19	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+2,500 sh	$14.57	+$36.4K	171,155
2024-11-18	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+7,500 sh	$15.00	+$113K	168,655
2024-09-20	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+2,633 sh	$18.97	+$49.9K	1,672,039
2024-09-20	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+2,367 sh	$17.88	+$42.3K	1,669,406
2024-09-19	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+5,000 sh	$17.89	+$89.5K	1,667,039
2024-09-18	ZBIOZenas BioPharma, Inc.P Purchase	Director, See Remarks	PPurchase	+10K sh	$17.91	+$179K	1,662,039
2024-09-16	ZBIOZenas BioPharma, Inc. · Series B Convertible Preferred StockC Conversion	Director, See Remarks	CConversion	−419K sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc. · Series B Convertible Preferred StockC Conversion	Director, See Remarks	CConversion	−3.23M sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc. · Series A Convertible Preferred StockC Conversion	Director, See Remarks	CConversion	−941K sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc. · Series Seed Convertible Preferred StockC Conversion	Director, See Remarks	CConversion	−1.43M sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	Director, See Remarks	CConversion	+48.3K sh	—	—	161,155
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	Director, See Remarks	CConversion	+372K sh	—	—	1,652,039
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	Director, See Remarks	CConversion	+108K sh	—	—	112,901
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	Director, See Remarks	CConversion	+165K sh	—	—	1,280,022
2024-09-16	ZBIOZenas BioPharma, Inc. · Series B Convertible Preferred StockC Conversion	Director, See Remarks	CConversion	−419K sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc. · Series B Convertible Preferred StockC Conversion	Director, See Remarks	CConversion	−3.23M sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc. · Series Seed Convertible Preferred StockC Conversion	Director, See Remarks	CConversion	−1.43M sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	Director, See Remarks	CConversion	+48.3K sh	—	—	156,635
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	Director, See Remarks	CConversion	+372K sh	—	—	536,540
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	Director, See Remarks	CConversion	+108K sh	—	—	108,381
2024-09-16	ZBIOZenas BioPharma, Inc. · Series A Convertible Preferred StockC Conversion	Director, See Remarks	CConversion	−941K sh	—	—	0
2024-09-16	ZBIOZenas BioPharma, Inc.C Conversion	Director, See Remarks	CConversion	+165K sh	—	—	164,523
2024-09-12	ZBIOZenas BioPharma, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+1.49M sh	—	—	1,486,000
2024-09-12	ZBIOZenas BioPharma, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+1.49M sh	—	—	1,486,000
2024-06-18	ZLABZai Lab LtdA Award	Director	AAward	+21.3K sh	—	—	61,771
2024-05-23	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2024-01-22	DNTHDianthus Therapeutics, Inc. /DE/A Award	Director	AAward	+167K sh	$12.00	+$2M	1,436,745
2023-09-11	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+6,500 sh	—	—	6,500
2023-06-29	ZLABZai Lab LtdA Award	Director	AAward	+18.9K sh	$26.45	+$500K	40,518
2023-06-15	TREVENA INCStock Option (Right to Buy)A Award	Director	AAward	+13.7K sh	—	—	13,700
2022-06-09	TREVENA INCStock Option (Right to Buy)A Award	Director	AAward	+100K sh	—	—	100,000
2022-01-03	ZLABZai Lab LtdA Award	Director	AAward	+7,763 sh	—	—	21,615
2021-05-28	TREVENA INCStock Option (Right to Buy)A Award	Director	AAward	+68.6K sh	—	—	68,577

Recent filings

Accepted (ET)
Jun 224
MOULDER LEON O JR0000905148-26-003025
SEC(opens sec.gov)
Jun 174
MOULDER LEON O JR0001104659-26-075256
SEC(opens sec.gov)
May 184
MOULDER LEON O JR0001104659-26-063362
SEC(opens sec.gov)
Apr 294
MOULDER LEON O JR0001104659-26-051889
SEC(opens sec.gov)
Mar 314
MOULDER LEON O JR0001104659-26-038031
SEC(opens sec.gov)
Feb 34
MOULDER LEON O JR0001104659-26-009756
SEC(opens sec.gov)
Jan 94
MOULDER LEON O JR0001104659-26-002589
SEC(opens sec.gov)
Oct 94
MOULDER LEON O JR0001104659-25-098413
SEC(opens sec.gov)
Jun 234
MOULDER LEON O JR0000905148-25-002219
SEC(opens sec.gov)
Jun 124
MOULDER LEON O JR0001104659-25-058914
SEC(opens sec.gov)
Feb 194
MOULDER LEON O JR0001104659-25-015145
SEC(opens sec.gov)
Dec 44
MOULDER LEON O JR0001104659-24-125677
SEC(opens sec.gov)
Nov 204
MOULDER LEON O JR0001104659-24-121081
SEC(opens sec.gov)
Sep 204
MOULDER LEON O JR0001104659-24-101773
SEC(opens sec.gov)

Companies

Address

C/O ZAI LAB LIMITED 314 MAIN STREET, 4TH FLOOR, SUITE 100

CAMBRIDGE, MA, 02142